Increased serum PCSK9 concentrations are associated with periodontal infection but do not correlate with LDL cholesterol concentration

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 154-159

  Miyazawa, Haruna ^a,b   Honda, Tomoyuki ^a,b   Miyauchi, Sayuri ^a,b   Domon, Hisanori ^a   Okui, Takafumi ^a,b   Nakajima, Takako ^a,c   Tabeta, Koichi ^a   Yamazaki, Kazuhisa ^a,b  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Chronic inflammation; LDL cholesterol; PCSK9; Periodontitis

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; INTERLEUKIN 6; KEXIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERINE PROTEINASE; SUBTILISIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY TITER; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPID ANALYSIS; LIPID METABOLISM; MALE; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; ANTIBODIES, BACTERIAL; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROPROTEIN CONVERTASES; SERINE ENDOPEPTIDASES; TUMOR NECROSIS FACTOR-ALPHA;

PORPHYROMONAS GINGIVALIS;

EID: 82955232910     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.09.023     Document Type: Article

References (33)

1. Humphrey L.L., Fu R., Buckley D.I., Freeman M., Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 2008, 23:2079-2086.
2. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-e171.
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
4. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
5. D'Aiuto F., Parkar M., Nibali L., Suvan J., Lessem J., Tonetti M.S. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 2006, 151:977-984.
6. Ramirez-Tortosa M.C., Quiles J.L., Battino M., et al. Periodontitis is associated with altered plasma fatty acids and cardiovascular risk markers. Nutr Metab Cardiovasc Dis 2010, 20:133-139.
7. Rufail M.L., Schenkein H.A., Koertge T.E., et al. Atherogenic lipoprotein parameters in patients with aggressive periodontitis. J Periodontal Res 2007, 42:495-502.
8. Shimazaki Y., Saito T., Yonemoto K., Kiyohara Y., Iida M., Yamashita Y. Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama Study. J Dent Res 2007, 86:271-275.
9. Yamazaki K., Honda T., Domon H., et al. Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease. Clin Exp Immunol 2007, 149:445-452.
10. Maekawa T., Takahashi N., Tabeta K., et al. Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One 2011, 6:e20240.
11. Russell D.W., Schneider W.J., Yamamoto T., Luskey K.L., Brown M.S., Goldstein J.L. Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor. Cell 1984, 37:577-585.
12. Yokoyama C., Wang X., Briggs M.R., et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993, 75:187-197.
13. Zelcer N., Hong C., Boyadjian R., Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009, 325:100-104.
14. Lambert G., Charlton F., Rye K.A., Piper D.E. Molecular basis of PCSK9 function. Atherosclerosis 2009, 203:1-7.
15. Seidah N.G., Benjannet S., Wickham L., et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci U S A 2003, 100:928-933.
16. Zhang D.W., Lagace T.A., Garuti R., et al. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. J Biol Chem 2007, 282:18602-18612.
17. Abifadel M., Varret M., Rabes J.P., et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 2003, 34:154-156.
18. Cohen J.C., Boerwinkle E., Mosley T.H., Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006, 354:1264-1272.
19. Chan J.C., Piper D.E., Cao Q., et al. A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates. Proc Natl Acad Sci U S A 2009, 106:9820-9825.
20. Khovidhunkit W., Kim M.S., Memon R.A., et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004, 45:1169-1196.
21. Kornman K.S., Crane A., Wang H.Y., et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997, 24:72-77.
22. Yamazaki K., Ohsawa Y., Tabeta K., et al. Accumulation of human heat shock protein 60-reactive T cells in the gingival tissues of periodontitis patients. Infect Immun 2002, 70:2492-2501.
23. Schei O., Waerhaug J., Lovdal A., Arno A. Alveolar bone loss as related to oral hygiene and age. J Periodontol 1959, 30:7-16.
24. Tabeta K., Tanabe N., Yonezawa D., et al. Elevated antibody titers to Porphyromonas gingivalis as a possible predictor of ischemic vascular disease. J Atheroscler Thromb 2011, 18:808-817.
25. Katz J., Flugelman M.Y., Goldberg A., Heft M. Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol 2002, 73:494-500.
26. Lösche W., Karapetow F., Pohl A., Pohl C., Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 2000, 27:537-541.
27. D'Aiuto F., Nibali L., Parkar M., Suvan J., Tonetti M.S. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005, 84:269-273.
28. Ruan X.Z., Varghese Z., Fernando R., Moorhead J.F. Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 1998, 13:1391-1397.
29. Ruan X.Z., Varghese Z., Powis S.H., Moorhead J.F. Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int 2001, 60:1716-1725.
30. Nakajima T., Honda T., Domon H., et al. Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease. J Periodontal Res 2010, 45:116-122.
31. Yamazaki K., Honda T., Oda T., et al. Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 2005, 40:53-58.
32. Noguchi T., Katsuda S., Kawashiri M.A., et al. The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation. Atherosclerosis 2010, 210:166-172.
33. Feingold K.R., Moser A.H., Shigenaga J.K., Patzek S.M., Grunfeld C. Inflammation stimulates the expression of PCSK9. Biochem Biophys Res Commun 2008, 374:341-344.